Genibet - Biopharmaceuticals SA

Genibet - Biopharmaceuticals SA is an SME in Oeiras, Portugal that has taken part in 10 EU-funded projects since 2008, receiving €5.1M in EU funding.

EU funding received€5.1M
EU projects10
As coordinator0
Running now2
First EU project2008
Latest project2024
CountryPortugal
EU registration (PIC)998123211
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Genibet - Biopharmaceuticals SA's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€2.3M · 4 projects
  • Horizon Europe€1.6M · 2 projects
  • Horizon 2020€1.2M · 4 projects

Projects

10 EU-funded projects, newest first. Each links to the official record.

  • CAAREAssociated partner

    Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • UltiMalVaxPartner

    A Vaccine Targeting Eradication of Malaria

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €1.6Mtheir share
  • TRANSVAC-DSPartner

    DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €12ktheir share
  • CRUZIVAXPartner

    Vaccine for prevention and treatment of Trypanosoma cruzi infection

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €861ktheir share
  • TRANSVAC2Partner

    European Vaccine Research and Development Infrastructure

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €109ktheir share
  • DiViNePartner

    Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €250ktheir share
  • HepaMAbPartner

    Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €1.5Mtheir share
  • BRAINVECTORSPartner

    From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV""

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €104ktheir share
  • SADELPartner

    Scaffolds for alternative delivery

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €469ktheir share
  • BRAINCAVPartner

    NONHUMAN ADENOVIRUS VECTORS FOR GENE TRANSFER TO THE BRAIN

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €252ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alkali metals
  • bacteriology
  • bioprocessing technologies
  • catalysis
  • cells technologies
  • gene therapy
  • hepatitis C
  • hepatology
  • immunology
  • immunotherapy
  • infectious diseases
  • inflammatory bowel disease
  • malaria
  • mass spectrometry

Genibet - Biopharmaceuticals SA is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime